116 related articles for article (PubMed ID: 35931556)
21. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.
Zhang Y; Xu Y; Wang D; Kuang T; Wu W; Xu X; Jin D; Lou W
Int J Clin Oncol; 2021 Jan; 26(1):135-144. PubMed ID: 32959232
[TBL] [Abstract][Full Text] [Related]
22. Development and multicenter validation of a nomogram for preoperative prediction of lymph node positivity in pancreatic cancer (NeoPangram).
Hua J; Chen XM; Chen YJ; Lu BC; Xu J; Wang W; Shi S; Yu XJ
Hepatobiliary Pancreat Dis Int; 2021 Apr; 20(2):163-172. PubMed ID: 33461937
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
Kamarajah SK; White SA; Naffouje SA; Salti GI; Dahdaleh F
Ann Surg Oncol; 2021 Oct; 28(11):6790-6802. PubMed ID: 33786676
[TBL] [Abstract][Full Text] [Related]
24. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study.
Zou W; Wang Z; Wang F; Zhang G; Liu R
BMC Cancer; 2021 May; 21(1):524. PubMed ID: 33964898
[TBL] [Abstract][Full Text] [Related]
25. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
[TBL] [Abstract][Full Text] [Related]
26. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
[TBL] [Abstract][Full Text] [Related]
27. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
Ren W; Xourafas D; Ashley SW; Clancy TE
Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
[TBL] [Abstract][Full Text] [Related]
28. Tumor fibrosis correlates with the survival of patients with pancreatic adenocarcinoma and is predictable using clinicoradiological features.
Shi S; Luo Y; Wang M; Lin Z; Song M; Li Z; Peng Z; Feng ST
Eur Radiol; 2022 Sep; 32(9):6314-6326. PubMed ID: 35420301
[TBL] [Abstract][Full Text] [Related]
29. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
31. Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram.
Mahjoub M; Sioson L; Sheen A; Ahadi M; Chou A; Gill AJ; Fuchs TL
Pathology; 2022 Feb; 54(1):79-86. PubMed ID: 34303553
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection.
Zhao B; Wang J; Ma Z; Ye H; Yang T; Meng K
Pathol Oncol Res; 2023; 29():1611014. PubMed ID: 37151355
[No Abstract] [Full Text] [Related]
34. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
35. The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort.
Huss A; Ihorst G; Timme-Bronsert S; Hasenburg A; Oehler MK; Klar M
Ann Surg Oncol; 2018 Dec; 25(13):3966-3973. PubMed ID: 30238246
[TBL] [Abstract][Full Text] [Related]
36. Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial.
Zhou J; Li T; Xiao Y; Lin J; Chen X; Peng S; Huang M; Shi X; Cai L; Huang P; Huang M
Ann Transl Med; 2022 Jun; 10(12):694. PubMed ID: 35845530
[TBL] [Abstract][Full Text] [Related]
37. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
[TBL] [Abstract][Full Text] [Related]
38. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.
Novotny AR; Schuhmacher C; Busch R; Kattan MW; Brennan MF; Siewert JR
Ann Surg; 2006 Jan; 243(1):74-81. PubMed ID: 16371739
[TBL] [Abstract][Full Text] [Related]
39. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
Correa-Gallego C; Do R; Lafemina J; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2013 Dec; 20(13):4348-55. PubMed ID: 24046103
[TBL] [Abstract][Full Text] [Related]
40. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
